Pretreatment EUS stage does not predict complete response (CR) to neoadjuvant chemoradiation in esophageal carcinoma

被引：0
|
作者：
Mallery, S
DeCamp, M
Bueno, R
Mentzer, S
Sugarbaker, D
Swanson, S
Van Dam, J
机构：
[1] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Thorac Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
GASTROINTESTINAL ENDOSCOPY | 1998年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
506
引用
收藏
页码：AB150 / AB150
页数：1
相关论文
共 50 条
  • [1] Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma
    Mallery, S
    DeCamp, M
    Bueno, R
    Mentzer, SJ
    Sugarbaker, DJ
    Swanson, SJ
    Van Dam, J
    [J]. CANCER, 1999, 86 (05) : 764 - 769
  • [2] Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma
    Chak, A
    [J]. CANCER, 2000, 88 (05) : 1184 - 1185
  • [3] Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma - Author reply
    Mallery, S
    Van Dam, J
    [J]. CANCER, 2000, 88 (05) : 1185 - 1186
  • [4] CAN CLINICAL COMPLETE RESPONSE PREDICT PATHOLOGIC COMPLETE RESPONSE FOLLOWING NEOADJUVANT CHEMORADIATION FOR ESOPHAGEAL CANCER?
    Holliday, Tyler L.
    Khaitan, Puja G.
    Carroll, Austin H.
    Hofstetter, Wayne L.
    Corsini, Erin M.
    Zhou, Nicolas
    Desale, Sameer
    Lazar, John F.
    Magolis, Marc
    Henderson, Hayley R.
    Malouf, Stefanie C.
    Hamm, Margaret E.
    Watson, Thomas J.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S927 - S927
  • [5] Does neoadjuvant chemoradiation downstage esophageal carcinoma?
    Slater, MS
    Holland, J
    Faigel, DO
    Sheppard, BC
    Deveney, CW
    [J]. AMERICAN JOURNAL OF SURGERY, 2001, 181 (05): : 440 - 444
  • [6] Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage
    C. R. Schmidt
    J. L. Tarpley
    J. R. Roberts
    A. S. Pearson
    M. C. Kelley
    M. Ninan
    J. D. Berlin
    A. B. Chakravarthy
    R. D. Beauchamp
    N. B. Merchant
    [J]. Annals of Surgical Oncology, 2004, 11 : S55 - S55
  • [7] Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage
    Schmidt, CR
    Tarpley, JL
    Roberts, JR
    Pearson, AS
    Kelley, MC
    Ninan, M
    Berlin, JD
    Chakravarthy, AB
    Beauchamp, RD
    Merchant, NB
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : S55 - S55
  • [8] Esophageal Cancer Stage: Does Dysphagia Predict EUS Tumor Stage in Esophageal Cancer
    Khehra, Raman
    Sharma, Tarun
    Dhawan, Manish
    Farah, Katie
    Alagugurusamy, Suresh
    Singh, Shailendra
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S23 - S23
  • [9] CAN PRETREATMENT RECTAL MRI PREDICT RESPONSE TO NEOADJUVANT CHEMORADIATION THERAPY?
    Chang, G.
    You, Y.
    Park, I.
    Kaur, H.
    Hu, C.
    Rodriguez-Bigas, M.
    Skibber, J.
    Ernst, R.
    [J]. DISEASES OF THE COLON & RECTUM, 2011, 54 (05) : E11 - E11
  • [10] DNA Repair Biomarkers Predict Response to Neoadjuvant Chemoradiation in Esophageal Cancer
    Alexander, B. M.
    Wang, X.
    Niemierko, A.
    Roof, K. S.
    Fidias, P. M.
    Mathisen, D. J.
    Weaver, D. T.
    Choi, N. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S91 - S91
12345